Skip to content

Clinical trials

Phase 2 Glioma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20141
20171
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Nationwide Children's Hospital2
Novartis Pharmaceuticals2
Fore Biotherapeutics1
Incyte Corporation1
Martin-Luther-Universität Halle-Wittenberg1
Rigel Pharmaceuticals1
University Hospital Freiburg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma11
Glioblastoma7
Astrocytoma5
Oligodendroglioma5
Diffuse Intrinsic Pontine Glioma4
Brain Neoplasms3
Central Nervous System Neoplasms3
Biliary Tract Neoplasms2
Gastrointestinal Stromal Tumors2
Thyroid Carcinoma, Anaplastic2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.